Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Blood|March 10, 2001
Interleukin-6 is a growth factor for nonmalignant human plasmablastsG Jego, R Bataille, C Pellat-DeceunynckLeukemia|April 22, 2006
Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptorsG Jego, R Bataille, A Geffroy-Luseau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cellsC Pellat-Deceunynck, G Jego, J L Harousseau, et al.British Journal of Pharmacology|October 8, 2003
Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss miceD J P David, M Bourin, G Jego, et al.Leukemia Research|June 27, 2000
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSFG Jego, H Avet-Loiseau, N Robillard, et al.Blood|July 9, 1999
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cellsG Jego, N Robillard, D Puthier, et al.European Journal of Immunology|March 31, 2000
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cellsC Pellat-Deceunynck, M P Mellerin, N Labarrière, et al.Journal of Neuroscience Methods|December 14, 2004
Rapid and precise method to locate microdialysis probe implantation in the rodent brainL Bert, D Favale, G Jego, et al.Leukemia|December 9, 1998
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myelomaC Pellat-Deceunynck, S Barillé, G Jego, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
CD28, a marker associated with tumoral expansion in multiple myelomaN Robillard, G Jego, C Pellat-Deceunynck, et al.Pageof 2